G6PD deficiency is the most common inherited metabolic disorder and clinically significant red cell enzyme defect in man. Severe neonatal jaundice proved to be the most common clinical manifestation and a globally important most dangerous consequence of G6PD deficiency. Prolonged jaundice is sometimes associated with congenital hypothyroidism. So the early characterization of G6PD activity and thyroid hormone levels provides an etiological diagnosis for neonatal jaundice as well as the opportunity to give the newborn's family information concerning hemolytic crisis prevention and an early management in case of hypothyroidism. Aim: This study was conducted in an attempt to evaluate the prevalence of G6PD deficiency and hypothyroidism in relation to neonatal physiological hyperbilirubinemia.
Introduction
Early-onset hyperbilirubinaemia is a high-risk condition because it often presents with an acute and rapid rise in bilirubin values. Although the outcome for most is benign, infants with extremely high serum bilirubin can develop acute bilirubin encephalopathy in the absence of urgent intervention
depending on the permeability of the blood brain barrier to bilirubin or albumin
. Neonatal hyperbilirubinemia, (defined as a serum total bilirubin level exceeding 5 mg/dl) is a frequent problem . Neonatal jaundice affects 60% of full-term infants and 80% of preterm infants in the first three days of life. Although transient, the condition accounts for up to 75% of hospital readmissions in the first week after birth (4) and it is a common reason for neonates to present in the emergency department
. Hyperbilirubinemia is caused both by increased production of bilirubin as the heme in red blood cells is broken down and by decreased bilirubin excretion due to inadequate hepatic conjugation and increased enterohepatic reabsorption (6) . Although physiological jaundice is more frequent as compared to pathological jaundice, it is very important to differentiate between the two, as pathological jaundice may lead to kernicterus and subsequently brain damage. Treatment is dependent upon the amount of serum bilirubin and various other laboratory investigations. Thus laboratory workup is very important for diagnosis and prevention of neonatal hyperbilirubinemia in newborn . Causes of pathological jaundice are heamolysis, breast feeding, infections, hypothyroidism and extrahepatic biliary atresia and needs investigation and medical intervention (8) .
Glucose-6-phosphate dehydrogenase is an xlinked recessive disease, where the deficiency of the enzyme causes a spectrum of clinical manifestations ranging from neonatal jaundice to chronic non-spherocytic anemia, to infection and drug-induced hemolysis (9) . Hypothyroidism is the disease state caused by insufficient production of thyroid hormones by the thyroid gland. Thyroid hormones are essential for normal organ growth, development and function. The major secretory product of the thyroid is a prohormone (T4), which is activated in peripheral tissues by outer ring deiodination to T3
(10)
. Prolonged jaundice is sometimes associated with congenital hypothyroidism which appears to be associated with the delayed maturation of hepatic uridine diphosphate glucoronyl transferase enzyme activity
(11)
.
Aim of the work
The aim of this work was to make an early detection of G6PD deficiency and hypothyroidism in neonates suffering from postnatal physiological jaundice in order to start early management.
Material and Methods
Fifty Egyptian neonates (6 hrs -5 days) were chosen for this study after agreement of their families. Forty jaundiced infants were selected from the Neonatal Care Unit of Tabarak Hospital. They were treated only with phototherapy and there was no need for blood transfusion. Other ten healthy infants matching the same age were taken as control. All of the neonates were full-term, with good weight for the gestational age and no malformations. Blood samples were collected from jaundiced and healthy neonates and each sample was divided into two parts: One part was used to separate serum to estimate C-Reactive protein (C-RP) 
Results
All the fifty cases of both jaundiced and healthy neonates were negative in the C-Reactive protein. Figure (1 Table ( 2) shows that the correlation of total bilirubin with TSH and T3 was significant at 0.05 level, while there was no significant difference with both T4 and G6PD. The mean level of G6PD enzyme activity was 14.93 U/gHb while in healthy neonates group it was 11.06 U/gHb as presented in figure (2). (Table  2) . Data presented in figure (3) showed the mean level of TSH in hyperbilirubinemic and healthy neonates groups (10.47 U/Iu ml) and (3.19 U/Iu ml respectively). In the jaundiced neonates group, TSH of 13 cases (33%) was higher than normal level, while 27 cases (67%) had normal hormone level as presented in table (1).
Correlation of TSH with both T4 and T3 was highly significant at 0.01 levels ( (Figure 7 ). Reticulocytes mean value in jaundiced neonates was much higher (7.45%) than that in healthy neonates group (1.1%) and it is presented in fig. (8) which also shows results of hematocrit mean that was slightly elevated (50.08%) in jaundiced neonates in comparison with that of control (48.0%). Moreover, hemoglobin mean concentration level in jaundiced neonates was 16.39gm/dl while it was 15.74gm/dl in healthy neonates (Fig.9) . The mean calculated values of MCH, MCV and MCHC in hyperbilirubinemic group as well as that in control group are shown in figure (10).
Discussion
Neonatal hyperbilirubinaemia is a common finding during the first postnatal week. Physiological jaundice occurs in first week of life in 60% of term and 80% of premature neonates. On the other hand, non physiologic or pathologic jaundice occurs in 5-10% of newborns which require intervention . It is well recognized that in G6PD deficiency, early destruction of RBCs under oxidative stress causes release of hemoglobin, which is subsequently metabolized to form bilirubin that leads to the development of hyperbilirubinemia of neonates (20, 21) . Hypothyroidism is the most common disorder arising from hormone deficiency (22) . Thyroxin (T4) which is the main product of the thyroid and circulates in plasma is converted to T3. T4, in many respects, is considered as a prohormone for the more potent T3
(23)
. In the present study: All the investigated parameters in healthy neonates were within the normal range. Reticulocytes in jaundiced neonates was higher than the normal values and this could explain the high mean value of G6PD enzyme because in normal blood, reticulocytes have about five times more activity than the oldest erythrocyte subpopulation . In the present study: G6PD percentage showed that only 5% (2 infants out of the forty hyperbilirubinemic neonates) were deficient in G6PD enzyme activity. Also the two cases were with normal levels of thyroid hormones and normal RBCs count. Incidence of G6PD deficiency in this study was in accordance with the finding of a study made on 2501 newborns and the overall incidence of G6PD deficiency was 3.2% (27) . Another study revealed that from 272 neonates 12 babies (4.4%) were found to have G6PD deficiency (28) . The current study revealed that, statistically, there was no correlation between bilirubin and G6PD enzyme. However, many studies showed significant correlation between G6PD deficiency and neonatal jaundice. Also those studies revealed that the severity of hyperbilirubinemia depends on degree of G6PD deficiency and that its prevalence in severe hyperbilirubinemia is more than moderate hyperbilirubinemia (29, 30) . Other studies agreed with the present study in that there is no statistical correlation between G6PD and jaundice and that jaundice is associated with normal and G6PD deficient status . Also, another study suggested that hemolysis is only partly responsible of jaundice and that decreased bilirubin conjugation and elimination play a major role in the pathogenesis of neonatal jaundice (32) . In the current study, G6PD was directly proportional with TSH and inversely proportional with T4. Earlier studies have shown that thyroid hormones do influence the levels of G6PD in the erythrocytes (33, 34) . In addition, many studies found that the levels and activity of the enzyme decreased in hyperthyroid and increased in hypothyroid patients (35) (36) (37) .
Of the 40 neonates, 7 cases (18%) had T4 values lower than normal. Of the seven neonates with low T4 six were with high TSH which indicated that they have hypothyroidism and the 7 th neonate was with normal TSH and should make free T4 hormone to ensure that he had hypothyroidism. The 7 neonates were with normal G6PD value but two of them had low RBCs count. Primary congenital hypothyroidism has a birth prevalence of 1:2750 (38) to 1:4000 newborns (39) but in jaundiced neonates ratio raises to 10% (40) . In this study, bilirubin showed no statistical significant correlation with T4, but it was directly proportional to T3. TSH result was similar to that of a study carried by (41) who recorded that total bilirubin values decreased as TSH increases. Bilirubin is increased in serum of critically-ill patients and was suggested as one of the factors causing the low T3 plasma concentrations in these patients, by the inhibition of T4 transport into the liver
(42)
. The decrease of thyroid hormones in case of hyperbilirubunemia is due to alterations of thyroid hormone metabolism in cases of unconjugated hyperbilirubinemia. These effects might involve inhibition of thyroid hormone uptake by their target cells
(43)
. On the other hand, other studies revealed that neither bilirubin nor biliverdin affected uptake of T3 or T4
(44)
. The present study demonstrated that TSH was inversely proportional with both T3 and T4 that represented the classic negative feedback mechanism of the thyroid axis . The goal of newborn screening is the presymptomatic detection of infants with congenital conditions so that treatment may be commenced as early as possible to prevent, or ameliorate, the long-term consequences of the condition
(47)
. An Egyptian study made by El-Menshay et al.
(48) concluded that the incidence of G6PD deficiency in jaundiced infants was high and signifies the role of G6PD deficiency in developing neonatal jaundice among Egyptian infants. So early screening programs should be instituted in countries where the deficiency is prevalent. Also Abdel Fattah et al.
(49) concluded that G6PD deficiency is an important cause for neonatal jaundice in Egyptians and neonatal screening for its deficiency is recommended. Newborn screening for congenital hypothyroidism followed by the early initiation of thyroid hormone treatment to normalize thyroxin (T4) concentrations has been shown to prevent intellectual disability i.e., mental retardation (50)
. Hypothyroidism after the age of three years, when most of the thyroid hormonedependent brain development is complete, results in slow growth and delayed skeletal maturation 
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Parameters Bilirubin G6PD TSH T4 G6PD Pearson Correlation 0.054 ---- ---- ---- Sig. (2-tailed) 0.741 ---- ---- ---- TSH Pearson Correlation -0.323-* 0.438** ---- ---- Sig. (2-tailed) 0.042 0.005 ---- ----
